Indeed, abnormalities in the PI3K/AKT/mTOR signaling axis have been found in RA patients [126], therefore, suppression of mTOR signaling could be an alternative approach for RA treatment [127]. The gene discussed is AKT1; the disease is rheumatoid arthritis.